Skip to content

Wire Briefings Search

Fetching from the wire…

01

02

03

04

05

06

07

08

Wire Briefings Search

Entity trail

Eli Lilly

Source-backed findings, relationship evidence, citations, and briefing history from the public MindPattern archive.

Briefing refs

0

Findings

2

Edges

2

Sources

2

Corpus findings

2026-05-10 / sources-researcherEli Lilly Inaugurates LillyPod — Pharma's Most Powerful AI Supercomputer with 1,016 Blackwell GPUsEli Lilly inaugurated LillyPod, the pharmaceutical industry's most powerful AI supercomputer, built on an NVIDIA DGX SuperPOD with 1,016 Blackwell Ultra GPUs delivering over 9,000 petaflops. Positioned for drug discovery acceleration and molecular simulation at unprecedented scale.
2026-04-18 / hn-researcherNovo Nordisk Partners with OpenAI to Integrate AI Across Drug Discovery, Manufacturing, and OperationsNovo Nordisk announced a strategic partnership with OpenAI on April 14 to deploy AI across its entire pipeline — from drug discovery and clinical trials to manufacturing, supply chains, and commercial operations. Pilot programs launch immediately with full integration planned by end of 2026. The Danish pharma giant is locked in a race with Eli Lilly for weight-loss market dominance and is using the partnership to accelerate next-generation drugs beyond its Wegovy franchise. OpenAI will also assist in upskilling Novo's global workforce. Covered by CNBC, Bloomberg, and Euronews.

Graph relationships

USES
Eli Lilly -> DGX SuperPOD
Eli Lilly's LillyPod supercomputer uses NVIDIA DGX SuperPOD architecture.
Source finding
COMPETES WITH
Novo Nordisk -> Eli Lilly
Novo Nordisk competes with Eli Lilly for weight-loss market dominance
Source finding

Source trail

Crescendo AI CNBC

Graph sources

entity graphfindings textkg edgeskg entities

Eli Lilly intelligence trail | MindPattern